Zhengye Biotechnology Holding Ltd [NASDAQ: ZYBT] gained 7.29% or 0.55 points to close at $8.09 with a heavy trading volume of 270186 shares.
If we look at the average trading volume of 608.09K shares, ZYBT reached to a volume of 270186 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Zhengye Biotechnology Holding Ltd [ZYBT]:
The Average True Range (ATR) for Zhengye Biotechnology Holding Ltd is set at 1.67, with the Price to Sales ratio for ZYBT stock in the period of the last 12 months amounting to 14.60. The Price to Book ratio for the last quarter was 9.84, with the Price to Cash per share for the same quarter was set at 0.02. Price to Free Cash Flow for ZYBT in the course of the last twelve months was 59.16 with Quick ratio for the last quarter at 0.81.
Trading performance analysis for ZYBT stock
Zhengye Biotechnology Holding Ltd [ZYBT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.24.
Zhengye Biotechnology Holding Ltd [ZYBT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Zhengye Biotechnology Holding Ltd [ZYBT] shares currently have an operating margin of 18.90% and a Gross Margin at 59.46%. Zhengye Biotechnology Holding Ltd’s Net Margin is presently recorded at 10.69%.
Return on Equity for this stock inclined to 4.07%, with Return on Assets sitting at 4.07%.
An analysis of Institutional ownership at Zhengye Biotechnology Holding Ltd [ZYBT]
There are presently around $0.02%, or 0.25%% of ZYBT stock, in the hands of institutional investors.
